State Street SPDR Bloomberg High Yield Bond ETF vs Tenet Healthcare Corporation — how do they compare? State Street SPDR Bloomberg High Yield Bond ETF trades at $92.73 (market cap $5.86B), while Tenet Healthcare Corporation trades at $260 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 3.6× State Street SPDR Bloomberg High Yield Bond ETF's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, State Street SPDR Bloomberg High Yield Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold State Street SPDR Bloomberg High Yield Bond ETF for 60 Days and Tenet Healthcare Corporation for 15 Days on average.
| JNK | THC | |
|---|---|---|
Market Cap | $5.86B | $20.98B |
Volume | 7,780,002 | 428,008 |
Sector | Fixed Income | Health |
52-Week High | $98.02 | $280.77 |
52-Week Low | $92.30 | $161.37 |
Typical Hold Time | 60 Days | 15 Days |
Enterprise Value | — | $32.06B |
Signals from Pluang's Aura AI — not financial advice
JNK trades at $92.76, down 0.13% with a bearish technical outlook. The ETF shows neutral oscillators but bearish moving averages, with key support at $92. Recent dividend distributions of $0.53 provide income, though financial ratios are unavailable. Market sentiment is influenced by rising bond yields and geopolitical tensions affecting high-yield debt markets.
Outlook remains cautious amid elevated Treasury yields and inflation concerns. The high-yield bond sector faces pressure from borrowing costs, though institutional interest persists. Key risks include interest rate volatility and economic slowdown impacting credit quality. Income-focused investors may find value in dividend yield despite market headwinds.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 53.31%, net margin 9.9%). Recent news highlights strong cash flow supporting capital returns and upcoming Q3 2026 results on October 29. Valuation appears reasonable with P/E of 10.07 and EV/EBITDA of 5.75.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and 7% upside to consensus target of $283.36. Key catalysts include sustained earnings momentum and efficient capital allocation. Risks include surgical volume pressures and cash flow sustainability concerns amid aggressive buybacks. The stock's current technical setup near pivot point $259 suggests balanced risk-reward.
Trailing returns across standard periods
JNK is a major ETF tracking the Bloomberg High Yield Very Liquid Index. It provides exposure to U.S. dollar-denominated junk bonds with above-average liquidity, featuring 2026 top holdings like EchoStar, Cloud Software Group, and Carnival Corp.
Read more on JNK →Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →